Dr. Wiesner on Importance of Genetic Testing for CRC

Georgia L. Wiesner, MD, MS
Published: Monday, Dec 28, 2015



Georgia L. Wiesner, MD, MS, director, Clinical and Translational Hereditary Cancer Program, Ingram Professor of Cancer Research, professor of Medicine, cancer geneticist, Vanderbilt-Ingram Cancer Center, discusses the importance of genetic testing for colorectal cancer (CRC).

Advancements have been made with genetic testing in the last 2 to 3 years, Wiesner explains. There are certain syndromes that account for a small number of people who are at high risk for developing CRC.

Genetic testing for these patients is important, Wiesner says, in order to gain a deeper understanding of the genes associated with the disease and what could cause it. Practitioners would also be able to do a surveillance approach for these patients.



Georgia L. Wiesner, MD, MS, director, Clinical and Translational Hereditary Cancer Program, Ingram Professor of Cancer Research, professor of Medicine, cancer geneticist, Vanderbilt-Ingram Cancer Center, discusses the importance of genetic testing for colorectal cancer (CRC).

Advancements have been made with genetic testing in the last 2 to 3 years, Wiesner explains. There are certain syndromes that account for a small number of people who are at high risk for developing CRC.

Genetic testing for these patients is important, Wiesner says, in order to gain a deeper understanding of the genes associated with the disease and what could cause it. Practitioners would also be able to do a surveillance approach for these patients.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x